Literature DB >> 33376112

Sphingosine-1-Phosphate Metabolism and Signaling in Kidney Diseases.

Yelena Drexler1, Judith Molina2, Alla Mitrofanova2, Alessia Fornoni2, Sandra Merscher1.   

Abstract

In the past few decades, sphingolipids and sphingolipid metabolites have gained attention because of their essential role in the pathogenesis and progression of kidney diseases. Studies in models of experimental and clinical nephropathies have described accumulation of sphingolipids and sphingolipid metabolites, and it has become clear that the intracellular sphingolipid composition of renal cells is an important determinant of renal function. Proper function of the glomerular filtration barrier depends heavily on the integrity of lipid rafts, which include sphingolipids as key components. In addition to contributing to the structural integrity of membranes, sphingolipid metabolites, such as sphingosine-1-phosphate (S1P), play important roles as second messengers regulating biologic processes, such as cell growth, differentiation, migration, and apoptosis. This review will focus on the role of S1P in renal cells and how aberrant extracellular and intracellular S1P signaling contributes to the pathogenesis and progression of kidney diseases.
Copyright © 2021 by the American Society of Nephrology.

Entities:  

Keywords:  ceramide; kidney disease; sphingolipid metabolism; sphingolipids; sphingosine-1-phosphate

Mesh:

Substances:

Year:  2020        PMID: 33376112      PMCID: PMC7894665          DOI: 10.1681/ASN.2020050697

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   14.978


  261 in total

1.  Sphingosine 1-phosphate phosphatase 2 is induced during inflammatory responses.

Authors:  Diana Mechtcheriakova; Alexander Wlachos; Jury Sobanov; Tamara Kopp; Roland Reuschel; Frederic Bornancin; Richard Cai; Barbara Zemann; Nicole Urtz; Georg Stingl; Gerhard Zlabinger; Maximilian Woisetschläger; Thomas Baumruker; Andreas Billich
Journal:  Cell Signal       Date:  2006-09-30       Impact factor: 4.315

2.  Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.

Authors:  Tae-Hyun Yoo; Christopher E Pedigo; Johanna Guzman; Mayrin Correa-Medina; Changli Wei; Rodrigo Villarreal; Alla Mitrofanova; Farah Leclercq; Christian Faul; Jing Li; Matthias Kretzler; Robert G Nelson; Markku Lehto; Carol Forsblom; Per-Henrik Groop; Jochen Reiser; George William Burke; Alessia Fornoni; Sandra Merscher
Journal:  J Am Soc Nephrol       Date:  2014-06-12       Impact factor: 10.121

3.  Activation of atypical protein kinase C by sphingosine 1-phosphate revealed by an aPKC-specific activity reporter.

Authors:  Taketoshi Kajimoto; Alisha D Caliman; Irene S Tobias; Taro Okada; Caila A Pilo; An-Angela N Van; J Andrew McCammon; Shun-Ichi Nakamura; Alexandra C Newton
Journal:  Sci Signal       Date:  2019-01-01       Impact factor: 8.192

4.  Molecular cloning and functional characterization of murine sphingosine kinase.

Authors:  T Kohama; A Olivera; L Edsall; M M Nagiec; R Dickson; S Spiegel
Journal:  J Biol Chem       Date:  1998-09-11       Impact factor: 5.157

5.  Transfer of phosphatidylcholine, phosphatidylethanolamine and sphingomyelin from low- and high-density lipoprotein to human platelets.

Authors:  B Engelmann; C Kögl; R Kulschar; B Schaipp
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

6.  Ceramide kinase uses ceramide provided by ceramide transport protein: localization to organelles of eicosanoid synthesis.

Authors:  Nadia F Lamour; Robert V Stahelin; Dayanjan S Wijesinghe; Michael Maceyka; Elaine Wang; Jeremy C Allegood; Alfred H Merrill; Wonhwa Cho; Charles E Chalfant
Journal:  J Lipid Res       Date:  2007-03-27       Impact factor: 5.922

7.  Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens.

Authors:  A Olivera; S Spiegel
Journal:  Nature       Date:  1993-10-07       Impact factor: 49.962

8.  Sphingosine 1-phosphate (S1P) induces COX-2 expression and PGE2 formation via S1P receptor 2 in renal mesangial cells.

Authors:  Anja Völzke; Alexander Koch; Dagmar Meyer Zu Heringdorf; Andrea Huwiler; Josef Pfeilschifter
Journal:  Biochim Biophys Acta       Date:  2013-09-21

9.  Inhibition of sphingosine kinase-2 in a murine model of lupus nephritis.

Authors:  Ashley J Snider; Phillip Ruiz; Lina M Obeid; Jim C Oates
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

10.  The interaction between C5a and sphingosine-1-phosphate in neutrophils for antineutrophil cytoplasmic antibody mediated activation.

Authors:  Jian Hao; Yi-Min Huang; Ming-Hui Zhao; Min Chen
Journal:  Arthritis Res Ther       Date:  2014-07-07       Impact factor: 5.156

View more
  8 in total

1.  Loss of sphingosine kinase 2 protects against cisplatin-induced kidney injury.

Authors:  Dengpiao Xie; Gaizun Hu; Chaoling Chen; Fereshteh Ahmadinejad; Weili Wang; Pin-Lan Li; David A Gewirtz; Ningjun Li
Journal:  Am J Physiol Renal Physiol       Date:  2022-07-14

2.  Ceramide-1-Phosphate as a Potential Regulator of the Second Sodium Pump from Kidney Proximal Tubules by Triggering Distinct Protein Kinase Pathways in a Hierarchic Way.

Authors:  Lindsey M P Cabral; Fernando G Almeida; Gloria M R S Grelle; Adalberto Vieyra; Celso Caruso-Neves; Marcelo Einicker-Lamas
Journal:  Curr Issues Mol Biol       Date:  2022-02-22       Impact factor: 2.976

3.  The sphingosine 1-phosphate receptor 2/4 antagonist JTE-013 elicits off-target effects on sphingolipid metabolism.

Authors:  Melissa R Pitman; Alexander C Lewis; Lorena T Davies; Paul A B Moretti; Dovile Anderson; Darren J Creek; Jason A Powell; Stuart M Pitson
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.379

4.  Neutral ceramidase deficiency protects against cisplatin-induced acute kidney injury.

Authors:  Sophia M Sears; Tess V Dupre; Parag P Shah; Deanna L Davis; Mark A Doll; Cierra N Sharp; Alexis A Vega; Judit Megyesi; Levi J Beverly; Ashley J Snider; Lina M Obeid; Yusuf A Hannun; Leah J Siskind
Journal:  J Lipid Res       Date:  2022-02-10       Impact factor: 5.922

5.  Tumor Necrosis Factor-α Induces a Preeclamptic-like Phenotype in Placental Villi via Sphingosine Kinase 1 Activation.

Authors:  Yuliya Fakhr; Saloni Koshti; Yasaman Bahojb Habibyan; Kirsten Webster; Denise G Hemmings
Journal:  Int J Mol Sci       Date:  2022-03-29       Impact factor: 5.923

6.  Mechanisms of podocyte injury and implications for diabetic nephropathy.

Authors:  Federica Barutta; Stefania Bellini; Gabriella Gruden
Journal:  Clin Sci (Lond)       Date:  2022-04-14       Impact factor: 6.124

7.  A UPLC-Q-TOF-MS-Based Metabolomics Approach to Screen out Active Components in Prepared Rhubarb for Its Activity on Noxious Heat Blood Stasis Syndrome.

Authors:  Hui Zhu; Yu Duan; Kunming Qin; Junjie Jin; Xiao Liu; Baochang Cai
Journal:  Front Pharmacol       Date:  2022-07-19       Impact factor: 5.988

8.  Optimization of Ultrafast Proteomics Using an LC-Quadrupole-Orbitrap Mass Spectrometer with Data-Independent Acquisition.

Authors:  Masaki Ishikawa; Ryo Konno; Daisuke Nakajima; Mari Gotoh; Keiko Fukasawa; Hironori Sato; Ren Nakamura; Osamu Ohara; Yusuke Kawashima
Journal:  J Proteome Res       Date:  2022-08-01       Impact factor: 5.370

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.